AFLAC Incorporated (AFL) Stock Analysis
Breakout setup
Financial Services · Insurance - Life
Hold if already holding. Not a fresh buy at $118.41, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.3% away).
Aflac provides supplemental health and life insurance in Japan (cancer, medical, nursing care) and the US (accident, disability, critical illness, hospital indemnity), with Aflac Japan as the principal earnings contributor and largest cancer/medical insurer in Japan. Aflac Japan... Read more
Hold if already holding. Not a fresh buy at $118.41, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.3% away). Chart setup: Golden cross, above all MAs, RSI 58, MACD bullish. Maintain position. Not compelling to add more. Score 6.5/10, high confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent Developments — AFLAC Incorporated
Latest news
- Wells Fargo Maintains Equal-Weight on Aflac, Lowers Price Target to $111 — benzinga May 5, 2026 negative
- Piper Sandler Maintains Overweight on Aflac, Lowers Price Target to $125 — benzinga May 1, 2026 neutral
- 9 Financials Stocks With Whale Alerts In Today's Session — benzinga Apr 30, 2026 neutral
- Barclays Maintains Underweight on Aflac, Lowers Price Target to $99 — benzinga Apr 30, 2026 negative
- Aflac Q1 2026 Earnings Call Transcript — benzinga Apr 30, 2026 neutral
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $118.41, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.3% away). Chart setup: Golden cross, above all MAs, RSI 58, MACD bullish. Maintain position. Not compelling to add more. Target $116.81 (-1.4%), stop $112.92 (−4.9%), A.R:R -2.3:1. Score 6.5/10, high confidence.
Take-profit target: $116.81 (-0.8% upside). Target $116.81 (-1.4%), stop $112.92 (−4.9%), A.R:R -2.3:1. Stop-loss: $112.92.
Analyst target reached - limited upside remaining; Near 52-week high (1.3% away).
AFLAC Incorporated trades at a P/E of 13.6 (forward 15.6). TrendMatrix value score: 7.0/10. Verdict: Hold.
23 analysts cover AFL with a consensus score of 2.8/5. Average price target: $112.
What does AFLAC Incorporated do?Aflac provides supplemental health and life insurance in Japan (cancer, medical, nursing care) and the US (accident,...
Aflac provides supplemental health and life insurance in Japan (cancer, medical, nursing care) and the US (accident, disability, critical illness, hospital indemnity), with Aflac Japan as the principal earnings contributor and largest cancer/medical insurer in Japan. Aflac Japan accounted for 53% of total adjusted revenues in 2025 and 76% of total assets; the company distributes through ~6,300 Japanese agencies and ~5,300 US agents/brokers.